NEWS
News Articles
CenExel Clinical Research Establishes Clinical Trial Centers Of Excellence Company
Unites Four of the Top US Clinical Research Facilities to Reduce Time and Cost for New Drug Development SALT LAKE CITY, July 18, 2019 /PRNewswire/ — CenExel Clinical Research, Inc., (“CenExel” or the “Company”) announces the creation of their Centers of Excellence company, which unites four of the most experienced clinical research units in the country to design…
Read MoreSharecare names Quest Diagnostics its preferred laboratory partner to advance digital health management
ATLANTA (July 12, 2019) – Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehensive digital…
Read MoreRemoval of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection
Washington, D.C. (July 11, 2019) – BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers’ rebates be passed along to seniors enrolled in the Medicare drug benefit program: “The administration has abandoned one of the only…
Read MoreIntent Solutions Joins University of Kentucky Program to Eliminate Hepatitis C in Appalachia
ATLANTA, Ga., July 8, 2019 /PRNewswire/ — Intent Solutions, an Atlanta-based company that provides technology to improve prescription drug safety and adherence, announced today that it is partnering with the University of Kentuckyin a $15 million federal grant program aimed at eliminating Hepatitis C in one eastern Kentucky county hardest hit by the disease. Intent Solutions recently signed a contract with the University of Kentucky to…
Read MoreNew pharma boss: Next EU Commission should be clear on how to protect innovation
The next EU Commission should take a stronger position on innovation in the pharma sector, the new leader of the European Federation of Pharmaceutical Industries and Associations (EFPIA) told EURACTIV.com in an interview. “It will be important for the next European Commission to make an official statement on how they feel about innovation and how…
Read MoreBIO Applauds Enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
Legislation will strengthen pipeline of medical countermeasures against serious public health threats Washington, DC (June 25, 2019) – The Biotechnology Innovation Organization (BIO) today applauds the enactment of the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act, signed into law by President Trump late yesterday. The law re-authorizes critical federal biodefense programs and agencies, including…
Read More